The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
Bach MA, Rockwood K, Zetterberg C, Thamsborg G, Hébert R, Devogelaer JP, Christiansen JS, Rizzoli R, Ochsner JL, Beisaw N, Gluck O, Yu L, Schwab T, Farrington J, Taylor AM, Ng J, Fuh V; MK 0677 Hip Fracture Study Group.
J Am Geriatr Soc. 2004 Apr;52(4):516-23.PMID: 15066065 [PubMed - indexed for MEDLINE]Related articles